Literature DB >> 33352902

Autoantibody Profiling in Plasma of Dengue Virus-Infected Individuals.

Hoa Thi My Vo1, Veasna Duong2, Sowath Ly3, Quan-Zhen Li4, Philippe Dussart2, Tineke Cantaert1.   

Abstract

Dengue is an arboviral disease caused by dengue virus (DENV) with high prevalence in tropical and sub-tropical regions. Autoimmune syndromes following dengue can be observed in long term follow up. Anti-DENV antibodies are cross-reactive with surface antigens on endothelial cells or platelets and could be involved in the pathogenesis of dengue. However, no studies have analyzed the autoantibody repertoire and its roles in dengue pathogenesis. Hence, we aimed to describe the autoantibody profile in dengue patients with different disease severities. We utilized a protein array with 128 putative autoantigens to screen for IgM and IgG reactivity in plasma obtained from healthy donors (n = 8), asymptomatic individuals infected with DENV (n = 11) and hospitalized dengue patients (n = 21). Even though the patient cohort is small, we show that 80 IgM and 6 IgG autoantibodies were elevated in DENV infected patients compared to age-matched healthy donors. Individuals undergoing a primary DENV infection showed higher amounts of IgG autoantibodies, not IgM autoantibodies, compared to individuals undergoing secondary infection. No differences were observed between asymptomatic and hospitalized dengue patients. Nineteen autoantibodies, which react against several coagulation and complement components, correlated with platelet counts in severe dengue patients. This current study provides a framework to explore a possible role of candidate autoantibodies in dengue immunopathogenesis.

Entities:  

Keywords:  autoantibody; dengue; infectious disease

Year:  2020        PMID: 33352902      PMCID: PMC7766539          DOI: 10.3390/pathogens9121060

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  4 in total

Review 1.  Long COVID: current status in Japan and knowledge about its molecular background.

Authors:  Akihiro Matsunaga; Shinya Tsuzuki; Shinichiro Morioka; Norio Ohmagari; Yukihito Ishizaka
Journal:  Glob Health Med       Date:  2022-04-30

2.  Subsets of Cytokines and Chemokines from DENV-4-Infected Patients Could Regulate the Endothelial Integrity of Cultured Microvascular Endothelial Cells.

Authors:  Marcio da Costa Cipitelli; Iury Amancio Paiva; Jéssica Badolato-Corrêa; Cíntia Ferreira Marinho; Victor Edgar Fiestas Solórzano; Nieli Rodrigues da Costa Faria; Elzinandes Leal de Azeredo; Luiz José de Souza; Rivaldo Venâncio da Cunha; Luzia Maria de-Oliveira-Pinto
Journal:  Pathogens       Date:  2022-04-26

3.  Antibody fucosylation predicts disease severity in secondary dengue infection.

Authors:  Tineke Cantaert; Jeffrey V Ravetch; Stylianos Bournazos; Hoa Thi My Vo; Veasna Duong; Heidi Auerswald; Sowath Ly; Anavaj Sakuntabhai; Philippe Dussart
Journal:  Science       Date:  2021-06-04       Impact factor: 47.728

4.  SARS-CoV-2 infection relaxes peripheral B cell tolerance.

Authors:  Moriah J Castleman; Megan M Stumpf; Nicholas R Therrien; Mia J Smith; Kelsey E Lesteberg; Brent E Palmer; James P Maloney; William J Janssen; Kara J Mould; J David Beckham; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2022-04-14       Impact factor: 17.579

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.